n(6)-carboxymethyllysine has been researched along with Alzheimer Disease in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fülöp, T; Haddad, M; Landri, S; Lepage, A; Perrotte, M; Ramassamy, C | 1 |
| Borghi, R; Monacelli, F; Odetti, P; Pacini, D; Serrati, C; Traverso, N | 1 |
| Chichelli, T; Munschauer, F; Ostrow, P; Sternberg, Z; Vaughan, M | 1 |
| Barnham, KJ; Hatsuta, H; Irie, K; Kaneko, T; Kinoshita, N; Murakami, K; Murata, N; Murayama, S; Noda, Y; Shimizu, T; Shirasawa, T; Tahara, S | 1 |
| Dei, R; Horie, K; Inagaki, T; Li, M; Miyata, T; Nakagomi, Y; Niwa, H; Sobue, G; Takeda, A; Washimi, Y; Watanabe, M; Yasuda, Y | 1 |
| Castellani, RJ; Ghanbari, HA; Ghanbari, K; Harris, PL; Jones, PK; Kubat, Z; Perry, G; Smith, MA; Wolozin, BL | 1 |
| Cruz-Sánchez, CZ; Cruz-Sánchez, FF; Gironès, X; Guimerà, A; Kalaria, R; Lafuente, JV; Makita, Z; Ortega, A; Sasaki, N | 1 |
| Ayala, V; Bellmunt, MJ; Dalfó, E; Ferrer, I; Pamplona, R; Portero-Otín, M; Prat, J | 1 |
| Castellani, RJ; Moreira, PI; Nunomura, A; Perry, G; Smith, MA; Zhu, X | 1 |
| Horie, K; Kurokawa, K; Maeda, K; Miyata, T; Sobue, G; Takeda, A; Yasuda, T; Yasuda, Y | 1 |
| Doyu, M; Goto, Y; Horie, K; Inagaki, T; Maeda, K; Miyata, T; Sobue, G; Takeda, A; Wakai, M; Watanabe, M; Yasuda, T; Yasuda, Y | 1 |
| Dei, R; Goto, Y; Inagaki, T; Li, M; Miyata, T; Nakagomi, Y; Niwa, H; Sobue, G; Takeda, A; Wakai, M; Watanabe, M; Yamamoto, M; Yasuda, T; Yasuda, Y | 1 |
| Atwood, CS; Castellani, RJ; Founds, H; Fujii, J; Harris, PL; Perry, G; Sayre, LM; Smith, MA; Taniguchi, N; Vitek, MP | 1 |
1 review(s) available for n(6)-carboxymethyllysine and Alzheimer Disease
| Article | Year |
|---|---|
Oxidative stress and neurodegeneration.
Topics: Aging; Alzheimer Disease; Glycation End Products, Advanced; Humans; Lysine; Nerve Degeneration; Oxidative Stress | 2005 |
12 other study(ies) available for n(6)-carboxymethyllysine and Alzheimer Disease
| Article | Year |
|---|---|
Circulating and Extracellular Vesicles Levels of N-(1-Carboxymethyl)-L-Lysine (CML) Differentiate Early to Moderate Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Arginine; Biomarkers; Cell Line; Diagnosis, Differential; Disease Progression; Extracellular Vesicles; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Mental Status and Dementia Tests; Neurons | 2019 |
Pentosidine determination in CSF: a potential biomarker of Alzheimer's disease?
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lysine; Male; Middle Aged; Peptide Fragments | 2014 |
AGE-RAGE in multiple sclerosis brain.
Topics: Adult; Alzheimer Disease; Brain; Case-Control Studies; Female; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Multiple Sclerosis; Pilot Projects; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2011 |
SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Enzyme Activation; Glycation End Products, Advanced; Humans; Inflammation; Lysine; Memory Disorders; Mice; Mice, Knockout; Neurons; Oxidation-Reduction; Protein Multimerization; Superoxide Dismutase; Superoxide Dismutase-1; Superoxides | 2011 |
Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease.
Topics: Adolescent; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lipid Peroxidation; Lysine; Male; Malondialdehyde; Neuroglia; Neurons; Oxidative Stress | 2002 |
Oxidative damage in cultured human olfactory neurons from Alzheimer's disease patients.
Topics: Aldehydes; Alzheimer Disease; Cell Line; Cells, Cultured; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Immunohistochemistry; Lipid Peroxidation; Lysine; Membrane Proteins; Neurons; Olfactory Mucosa; Oxidative Stress | 2004 |
N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain; Cytoplasm; Diabetes Mellitus; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Neurofibrillary Tangles; Neurons; Plaque, Amyloid; tau Proteins | 2004 |
Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blotting, Western; Brain; Carbon; Cerebral Cortex; Databases as Topic; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Fatty Acids; Fatty Acids, Unsaturated; Female; Glial Fibrillary Acidic Protein; Glycation End Products, Advanced; Glycolysis; Humans; Lipid Metabolism; Lipid Peroxidation; Lysine; Male; Malondialdehyde; NADH Dehydrogenase; Oxygen; Phenylhydrazines; Proteins; Silver Staining; Ubiquinone | 2005 |
Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons.
Topics: Adolescent; Aged; Aging; Alzheimer Disease; Arginine; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lipofuscin; Lysine; Nerve Degeneration; Nerve Tissue Proteins; Neurons | 1997 |
Advanced glycation end products co-localized with astrocytes and microglial cells in Alzheimer's disease brain.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Arginine; Astrocytes; Cytoplasmic Granules; Extracellular Space; Glycoconjugates; Hippocampus; Humans; Lysine; Microglia; Staining and Labeling | 1998 |
Neuronal and glial advanced glycation end product [Nepsilon-(carboxymethyl)lysine]] in Alzheimer's disease brains.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Neuroglia; Neurons | 2001 |
Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Case-Control Studies; Free Radicals; Glycation End Products, Advanced; Glycosylation; Humans; Lysine; Middle Aged; Neurofibrillary Tangles | 2001 |